Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, Specialty Medicines - Respiratory

Job description

Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, Specialty Medicines - Respiratory Robust real-world evidence and health outcomes data is necessary to support launch optimization, reimbursement and maintain market position in today’s healthcare environment.  Evidence must be developed throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. We need to engage with our customers to understand how they define value and to effectively collaborate with them to ensure we are generating evidence that is impactful for payers, health systems, providers, and patients. The role of Senior Director, Global Real-World Evidence & Health Outcomes Research (GRWE& HO) Lead, Respiratory, will provide strategic real-world evidence and health outcomes leadership for assigned Respiratory asset(s) and is critical to achieving this ambition by ensuring that each medicine GSK brings to market is supported by scientifically credible, high-quality evidence that drives competitiveness and strong evidence-based product positioning, value propositions and value-based pricing.  The role is essential for the alignment of evidence with the requirements of customers responsible for marketing authorization, recommendation and reimbursement leading to successful patient access, product use and commercial success. The role will provide strategic and methodological leadership in the development of integrated evidence strategies across the asset lifecycle and communicate those strategies and their implications effectively to senior stakeholders. Key Responsibilities include, but are not limited to: The role will be a key member of the Global Real-World Evidence & Health Outcomes Research Specialty LT and other relevant matrix leadership teams.  The Senior Director, Global Real-World Evidence & Health Outcomes Research Lead will be accountable for ensuring team members engage closely with medical and matrix stakeholders and partner effectively in evidence strategy and data generation plan (DGP) planning, design, execution, translation, and dissemination for assigned Respiratory asset(s). The role will build trusted relationships with key stakeholders, positioning GRWE&HO as a strategic partner and source of scientific and methodological expertise. Provide leadership, management, and development of Data Generation book of work, including development of integrated real-world evidence and health outcomes strategies across the asset lifecycle. Partner and communicate effectively with matrix stakeholders in planning and design of the DGP for the asset, drive disciplined execution of studies and activities, translate results, and disseminate data and research findings to all relevant internal and external stakeholders. Provide scientific leadership for best practice in real world evidence, including non-interventional and pragmatic/hybrid interventional study approaches, enabling external scientific advice and ensuring appropriate protocol review committee’s advice sought and incorporated. Drive innovation and inform ideas and options through effective engagement with external experts, clinical guideline groups, HTA agencies, methodology and policy forums, and by leveraging knowledge of the external policy and decision maker environment to enable more efficient evidence development for the asset across the lifecycle (e.g. discovery, launching and life cycle management assets), including building external scientific collaborations and partnerships with key experts and institutions. Integrate excellent understanding of the evolving global health technology assessment bodies, clinical guidelines groups, policy decision makers and payer environment, including recommendation, reimbursement, pricing, and access in relevant therapy area. Lead discussions with key stakeholders on prioritization of data generation in order to meet business and customer needs, building trusted partnerships and contributing to strategic asset and senior leadership teams. Deliver the materials to inform internal governance decision making (e.g. Medical Review Board, etc) with the ability to communicate complex evidence strategies, methodological considerations and recommendations clearly and credibly at an executive level. Facilitate alignment and partnership to enable more effective interactions within the complex stakeholder matrix, e.g. clinical, commercial, market access, medical affairs functions, priority market LOCs as well as external third-party suppliers, building trust and positioning GRWE&HO as a strategic evidence partner. Represent GSK in external collaborations, engagement and scientific evidence requirements with scientific partners, reimbursement bodies and other decision makers, and establish productive collaborations with leading external experts, academic institutions and other scientific partners. Drive quality and compliance through team to ensure trust for the evidence that is delivered. Drive discipline in performance reporting and ensure studies are delivered according to plan and within budget. Why you? Basic Qualifications: We are looking for professionals with these required skills to achieve our goals: PhD, PharmD or equivalent level qualification in epidemiology, health outcomes, patient reported outcomes, health economics, pharmacy, or health sciences. Considerable experience working in global pharmaceuticals in a leadership role with line management experience. Experience within the respiratory therapeutic area or a closely related field. Strong business acumen and ability to translate customer needs into actionable data generation plan and integrated evidence strategies. Methods expertise to guide and lead team in delivering robust real-world evidence and payer evidence deliverables and credibility to engage meaningfully with external experts & leaders in the field, and to act as a trusted methodological advisor to internal stakeholders. Knowledge of the diversity and complexity of healthcare markets, health technology assessment agencies, and reimbursement decision making globally, in region and in local markets. Understanding of how real-world evidence, health economics, health outcomes, comparative effectiveness research, PRO research and the use of PRO instruments can be applied at local decision-making levels, including support of clinical practice. Deep knowledge and strong communication skills are critical for interpreting and translating complex concepts and results effectively to a variety of audiences, including senior executives, to impact decision making. Strong matrix leadership and stakeholder management skills, with the ability to work independently, and build trusted strategic partnerships and credibility across the enterprise. Experience across product lifecycles. Deep knowledge of drug development and therapy area. Experience leading a complex portfolio of projects, stakeholders, and other analytic staff in a senior role, including development and delivery of evidence strategies that inform asset and portfolio decision making. Demonstrated experience building external scientific collaborations and engaging effectively with leading external experts, academic institutions, research networks, and other scientific partners. Preferred Qualifications: If you have the following characteristics, it would be a plus: Experience in above country and in country roles. Direct experience with, or strong familiarity with, pragmatic clinical trials, hybrid interventional/real-world study designs, and other innovative approaches to evidence generation. Experience supporting assets in complex competitor landscapes. Direct payer experience. Launch experience. Portfolio of high value publications and/or scientific promotions. We are committed to creating an inclusive workplace where everyone can thrive. If you are passionate about making a difference an